These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 39441582)

  • 1. ALKBH5 Regulates Corneal Neovascularization by Mediating FOXM1 M6A Demethylation.
    Wang W; Li H; Qian Y; Li M; Deng M; Bi D; Zou J
    Invest Ophthalmol Vis Sci; 2024 Oct; 65(12):34. PubMed ID: 39441582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALKBH5-mediated m
    Hao L; Yin J; Yang H; Li C; Zhu L; Liu L; Zhong J
    Aging (Albany NY); 2021 Jan; 13(3):4045-4062. PubMed ID: 33428593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of AlkB homolog 5 suppresses the progression of non-small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11.
    Huang Z; Lin G; Hong Y; Weng L; Zhu K; Zhuang W
    Environ Toxicol; 2024 Jul; 39(7):4035-4046. PubMed ID: 38642004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
    Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
    Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALKBH5 activates FAK signaling through m6A demethylation in
    Sun R; Yuan L; Jiang Y; Wan Y; Ma X; Yang J; Sun G; Zhou S; Wang H; Qiu J; Zhang L; Cheng W
    Theranostics; 2023; 13(2):833-848. PubMed ID: 36632222
    [No Abstract]   [Full Text] [Related]  

  • 6. ALKBH5 Modulates Asthma Progression by Downregulating N6-methyladenosine Methylation.
    Fan X; Wei C; Han Y
    Iran J Allergy Asthma Immunol; 2024 Apr; 23(2):211-219. PubMed ID: 38822515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of m6A demethylase ALKBH5 alleviates hypoxia-induced pulmonary arterial hypertension via inhibiting Cyp1a1 mRNA decay.
    Gu N; Shen Y; He Y; Li C; Xiong W; Hu Y; Qiu Z; Peng F; Han W; Li C; Long X; Zhao R; Zhao Y; Shi B
    J Mol Cell Cardiol; 2024 Sep; 194():16-31. PubMed ID: 38821243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. m6A mRNA methylation-mediated MAPK signaling modulates the nasal mucosa inflammatory response in allergic rhinitis.
    Wang R; Liang J; Wang Q; Zhang Y; Lu Y; Zhan X; Wang S; Gu Q
    Front Immunol; 2024; 15():1344995. PubMed ID: 39011034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A.
    Zhao Y; Hu J; Sun X; Yang K; Yang L; Kong L; Zhang B; Li F; Li C; Shi B; Hu K; Sun A; Ge J
    Clin Transl Med; 2021 May; 11(5):e402. PubMed ID: 34047466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALKBH5 is a prognostic factor and promotes the angiogenesis of glioblastoma.
    Fan Y; Yan D; Ma L; Liu X; Luo G; Hu Y; Kou X
    Sci Rep; 2024 Jan; 14(1):1303. PubMed ID: 38221546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.
    Yang Z; Cai Z; Yang C; Luo Z; Bao X
    EBioMedicine; 2022 Jun; 80():104019. PubMed ID: 35490460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m
    Zhang L; Su X
    Cell Oncol (Dordr); 2022 Jun; 45(3):355-365. PubMed ID: 35579750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B.
    Gong H; Liu L; Cui L; Ma H; Shen L
    Mol Carcinog; 2021 Sep; 60(9):644-657. PubMed ID: 34169564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.
    Zhang D; Ning J; Okon I; Zheng X; Satyanarayana G; Song P; Xu S; Zou MH
    Cell Death Dis; 2021 May; 12(6):518. PubMed ID: 34016959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALKBH5 induces fibroblast-to-myofibroblast transformation during hypoxia to protect against cardiac rupture after myocardial infarction.
    Yang K; Zhao Y; Hu J; Gao R; Shi J; Wei X; Chen J; Hu K; Sun A; Ge J
    J Adv Res; 2024 Jul; 61():193-209. PubMed ID: 37689242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m
    Zhang S; Zhao BS; Zhou A; Lin K; Zheng S; Lu Z; Chen Y; Sulman EP; Xie K; Bögler O; Majumder S; He C; Huang S
    Cancer Cell; 2017 Apr; 31(4):591-606.e6. PubMed ID: 28344040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of ALKBH5 inhibits inflammation and excessive proliferation by promoting TRIM13 m6A modifications in glomerular mesangial cells.
    Hu X; Liu T; Zhuang X; Wei L; Gao J
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Sep; 397(9):6779-6789. PubMed ID: 38536435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.
    Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H
    Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.
    Qu S; Jin L; Huang H; Lin J; Gao W; Zeng Z
    BMC Cancer; 2021 Jun; 21(1):686. PubMed ID: 34112124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALKBH5-m
    Chao Y; Shang J; Ji W
    Biochem Biophys Res Commun; 2020 Jan; 521(2):499-506. PubMed ID: 31677788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.